Microvast Holdings, Inc. (NASDAQ:MVST - Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors purchased 12,681 call options on the stock. This represents an increase of approximately 113% compared to the average daily volume of 5,956 call options.
Wall Street Analyst Weigh In
MVST has been the subject of several research analyst reports. Zacks Research upgraded Microvast from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, August 13th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Microvast in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $3.00.
View Our Latest Research Report on MVST
Microvast Trading Up 21.1%
Shares of NASDAQ MVST traded up $0.92 during midday trading on Monday, hitting $5.25. The stock had a trading volume of 10,253,878 shares, compared to its average volume of 8,278,470. The company's 50-day simple moving average is $3.25 and its 200 day simple moving average is $3.07. The firm has a market cap of $1.71 billion, a P/E ratio of -10.33 and a beta of 3.22. Microvast has a fifty-two week low of $0.15 and a fifty-two week high of $5.40. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.83 and a quick ratio of 0.56.
Microvast (NASDAQ:MVST - Get Free Report) last released its earnings results on Monday, August 11th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $91.34 million during the quarter, compared to analysts' expectations of $106.79 million. Microvast had a positive return on equity of 10.32% and a negative net margin of 26.82%. Microvast has set its FY 2025 guidance at EPS. Research analysts anticipate that Microvast will post -0.3 EPS for the current year.
Institutional Investors Weigh In On Microvast
A number of institutional investors have recently made changes to their positions in MVST. JPMorgan Chase & Co. grew its stake in shares of Microvast by 680,832.5% during the second quarter. JPMorgan Chase & Co. now owns 3,118,671 shares of the company's stock worth $11,321,000 after purchasing an additional 3,118,213 shares during the period. Geode Capital Management LLC grew its stake in shares of Microvast by 117.3% during the second quarter. Geode Capital Management LLC now owns 4,635,584 shares of the company's stock worth $16,830,000 after purchasing an additional 2,502,565 shares during the period. Millennium Management LLC grew its stake in shares of Microvast by 101.6% during the first quarter. Millennium Management LLC now owns 4,646,060 shares of the company's stock worth $5,436,000 after purchasing an additional 2,341,637 shares during the period. Bank of America Corp DE grew its stake in shares of Microvast by 349.0% during the second quarter. Bank of America Corp DE now owns 1,636,970 shares of the company's stock worth $5,942,000 after purchasing an additional 1,272,420 shares during the period. Finally, Goldman Sachs Group Inc. grew its stake in shares of Microvast by 158.9% during the first quarter. Goldman Sachs Group Inc. now owns 1,606,896 shares of the company's stock worth $1,880,000 after purchasing an additional 986,335 shares during the period. 20.72% of the stock is owned by institutional investors and hedge funds.
Microvast Company Profile
(
Get Free Report)
Microvast Holdings, Inc provides battery technologies for electric vehicles and energy storage solutions. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, and nickel manganese cobalt version 1 and 2. It also designs, develops, and manufactures battery components, such as cathode, anode, electrolyte, and separator.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Microvast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microvast wasn't on the list.
While Microvast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.